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PREVALENCE OF INFECTION WITH
HUMAN HERPESVIRUS slKAPOSI'S
SARCOMA HERPESVIRUS IN
RURAL SOUTH AFRICA
David Wilkinson, Julie Sheldon, Charles F Gilks,
Thomas F Schulz
Objective. To determine prevalence of infection with human
herpesvirus 8 (HHV-8)/Kaposi's sarcoma herpesvirus
(KSHY) and to gain some insight into possible transmission
dynamics of this novel virus in South Africa.
Methods. Stored, anonymous serum from 50 patients with a ~
sexually transmitted disease (STD), 50 adult medical ward _.
patients (25 male, 25 female), and 36 paediatric ward patients
in Hlabisa Hospital, KwaZulu-Natal, was screened by
enzyme-linked immunosorbent assay (ELISA) for antibodies
to the small capsid-related protein encoded by HHV-8/KSHY
orf65. Antibodies to the latency-associated nuclear antigen
(LANA) were measured by immunofluorescence, and sera
that were reactive in the ELISA but negative by
immunofluorescence were re-tested by Western blot against
the recombinant orf65 protein to exclude nonspecific
reactivity_
Results. Overall, 47 patients tested positive (34.6%), 76 tested
negative (55.9%) and 13 (95%) had indeterminate results.
Among those with a definite result, prevalence was similar
among males (47.2%) and females (52.8%) and increased in
later adulthood « 18 months 375%,19 -120 months 385%,
15 - 34 years 32.1%, 35 - 69 years 62.8%). Prevalence was
highest among medical patients (58-1%); among those with
an STD it was 31.1% (P = 0-01), and among children it was
22.8% (P = 0.001). When age-adjusted, prevalence among
medical patients (23.7%) was similar to that among patients
with an STD.
Conclusion. Prevalence of HHV-8/ KSHY is high in this setting
and transmission appears to be occurring in childhood as
well as among adults. Larger population-based studies are
required to detail the transmission dynamics of HHSV-
8/KSHv.
5 Afr Afed /1999; 8!r. 554-~7.
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ORIGINAL ARTICLES
THe new human herpesvirus (HHV-8), or Kaposi's sarcoma-
as~ociatedherpesvirus (KSHV), is consistently detected in
AIDS-related, 'classic', endemic and post-transplant Kaposi's
saicoma (KS)l.5 The detection of KSHV in peripheral blood, as
w€ll as the presence of antibodies to KSHV, are strongly associated
with having, or being at risk for, KS.... KSHV infects the
en40thelial tumour (KS spindle) cells where it expresses a set of
latent genes; it also occasionally undergoes lytic replication-9-l2
Several of the KSHV genes expressed in KS tissue have the
potential to affect the control of normal cell proliferation. Taken
to~ether, this evidence strongly suggests that KSHV is the
infectious cause of KS and a new human tumour virus. On its own
th~ virus rarely leads to the development of KS tumours; however,
infection with HIV-1 dramatically increases both the frequency and
th~ clinical severity of KS.
KSHV is not thought to be ubiquitous, and is believed to be
m;1inly sexually transmitted in the USA and northern Europe.
AIltibodies to KSHV are much more frequent among
homosexual HIV-infected men than among HIV-infected
patients with haemophilia or intravenous drug users; they are
abo more common among HIV-uninfected heterosexual STD
clinic attendees than in healthy blood donors.
'
:>-18
Most sero-epidemiological studies have shown that the
prevalence of KSHV is low « 5%) in the general population of
Britain and North America, a little higher in Mediterranean
populations where 'classic' KS is more often observed, and
highest in parts of Africa, where it may reach 50%.'6-19 KS is
rela"tively infrequent in South Africa,'" but more cases are being
diagnosed in association with the rapidly expandi...'g HIV
epidemic (personal observations). Although KSHV has been
detected in South African KS specimens,21 its prevalence in
South African populations is unknown. In order to investigate
the prevalence of KSHV infection in South Africa and to begin
to gain some insights into" its likely routes of transmission we
smdied the prevalence of KSHV among patients attending a
rural district hospital in KwaZulu-Natal.
Survey
We selected spare se= left over from routine clinical tests
done on 136 patients that had been stored and made
anonymous. Fifty consecutive adult medical inpatients who
were tuberculosis suspects but had no active STD (25 women
and 25 men), 50 patients with a proven STD, and 36 paediatric
inpatients ~th a variety of common illnesses (diarrhoeal
disease, acute respiratory infection and malnutrition) were
chosen. Se= samples had all patient identifiers removed;
only age and sex identifiers were retained. Se= was stored
frozen at minus 20°C until tested in the Department of Genito-
urinary Medicine, University of Liverpool, UK, under a South
African Department of Health permit.
Serological methods
As described previously,I. sera were screened by enzyme-
linked immunosorbent assay (ELISA) in a dilution of 1:100 for
antibodies to the small capsid-related protein encoded by
KSHV orf65, using the average of 10 KSHV seronegative UK
blood donors plus 5 standard deviations (SDs) as a cut-off
value. As a control antigen we used a purified recombinant
dihydrofolate reductase protein, the fusion partner of the
recombinant orf65 protein.I. Antibodies to the 'latency-
associated nuclear antigen' (LANA)13.19 were measured by
immunofluorescence on paraformaldehyde fixed B-cell
precursor-1 cells, using a se= dilution of 1:150.
'
• Sera that
were reactive in the EUSA but negative by
immunofluorescence (IFA) were re-tested by Western blot
against the recombinant orf65 protein to exclude nonspecific
reactivityl. A positive result was recorded if both ELISA and
IFA were positive, if IFA alone was positive, or if samples
positive by ELISA but negative by IFA were confirmed positive
on Western blot with the recombinant orf65 protein (Fig. 1).
Negative samples were negative on both ELISA and IFA, and
indeterminate samples were those with a nonspecific
immunofluorescence or Western blot pattern.
METHODS
Setting
Hlabisa health district is situated in northern KwaZulu-Natal
and is home to around 210 000 Zulu-speaking people. The
district is relatively poor and underdeveloped. The HIV
epidemic has spread rapidly in KwaZulu-Natal; in Hlabisa HIV
pr·evalence among women attending antenatal clinics increased
frl)m 4.2% in 199222 to 28.9% in 1998 (A Harrison-
UIlpublished data). Sexually transmitted diseases (STDs) are
all:;o highly endemic in the area - we have estimated that
around 25% of women of reproductive age have at least one
Srn on any given day."
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Fig. 1. Western blot examination displaying orf65 protein.
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Analysis
Data were entered into an EpiInio database and analysed with
the same software. Proportions were compared with the chi-
square test, with P < 0.05 defined as the level of statistical
significance. Indirect age-standardisation was done for
comparison of medical and STD patient groups.
RESULTS
Overall, 47 (34.6%) of the 136 patients tested positive for KSHY,
76 (55.9%) tested negative and 13 (9.5%) had indeterminate
results. Among those with a definite result, prevalence was
similar among males (47.2%) and females (52.8%). Among
adults, prevalence increased with age (Table I), and was
significantly lower among young adults aged 15 - 34 years
(17/53,32.1 %) than among older adults aged 35 - 69 years
(22/35,62.8%, P = 0.004). Among those aged under 18 months,
3 (37.5%) had antibodies to KSHY, but it is possible that some
of this reactivity reflected persisting maternal antibodies. One
of the 3 children was aged between 12 and 18 months. Among
children aged 19 - 20 months 5 of 13 (38.5%) had antibodies.
Table I. Age-specific prevalence rates of infection with human
herpesvirus 8/Kaposi's sarcoma herpesvirus among selected
patients in lllabisa, KwaZulu-Natal
Positive
Age group No./total %
< 18 months 3/8. 37.5
19 -120 months 5/13 38.5
15 - 24 years 10/32 31.3
25 -34 years 7/21 30.0
35 - 44 years 10/18 55.6
45 -54 years 3/5 60.0
55 - 69 years 9/12 75.0
Prevalence was highest among medical inpatients (25/43,
58.1%). Among those with an STD it was Significantly lower at
31.1% (14/45, P = 0.01). However, when age-adjusted,
prevalence among medical patients (23.7%) was similar to that
among patients with an STD. Seroprevalence among all
children (8/35, ??8%) was also significantly lower than among
adult medical inpatients (P = 0.001). Prevalence was similar
among males and females in each of the three patient groups.
DISCUSSION
Our data suggest that HlN-8 is highly prevalent in this part of
South Africa. The positive serological results in children under
18 months of age may reflect passi~e transfer of maternal
antibodies. We also detected infection among children aged
19 - 35 months (3/6,50%). This observation is in line with a
recent report from Uganda, where seroprevalence increased
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steeply in children over 2 years of age to reach adult levels
before puberty." This age-dependent increase suggests that
horizontal transmission plays an important role in young
children in Africa, but vertical transmission cannot be excluded
at present. While the exact mechanism of horizontal
transmission remains to be identified, KSHV has been detected
in saliva by both polymerase chain reaction and culture}5.2h
suggesting that, as for other herpesviruses, transmission via
saliva under conditions of crowding and poor hygiene may
play an important role.
Prevalence of infection was similar in males and females in
all age groups. We noted a significantly higher seroprevalence
in adults over 34 years of age compared with younger adults.
In a recent study of Italian blood donors we noted a similar
increase in donors older than 55 years. The pattern of age-
specific increase in seroprevalence among these donors is more
suggestive of a reactivation of KSHV infection at higher age, 9~
of a cohort effect, than of sexual transmission. The small
number of sera tested in the present study does not allow us to
discriminate between these two possibilities and a more
extensive study is required.
When we adjusted the prevalence among adult patients in
this study for age, prevalence was found to be similar to that of
patients presenting with an STD. The higher crude prevalence
in medical patients therefore simply reflects their higher age.
The serum samples that we studied were not randomly
selected from the community, but were a convenience sample
of patients admitted to or presenting to hospital. As such the
prevalence rates reported here may overestimate community
prevalence; however they do suggest that KSHV is prevalent in
the area and that further study is warranted. It will be
important to perform large-scale community-based sera-
epidemiological studies to determine age- and sex-specific
prevalence and incidence, as well as to determine risk factors
for transmission, association with other viruses such as
hepatitis B, the association with KS and other malignancies;
and the extent to which vertical transmission occurs.
In North America most people dually infected with HIV
and KSHV go on to develop KS. In Uganda, KS has becoqle the
most common tumour, now accounting for 48% of reported
tumours compared with only 2% 20 years ago.'! If KSHV is as
widespread in South Africa as our findings suggest, it is
possible that a similar epidemic of HIV-associated KS could
also emerge here, providing yet another HIV-related care
challenge. Clinicians working in high-prevalence settings have
already noted an increase in cases. In addition, therefore, to
sero-epidemiological studies of KSHV, sentinel cancer
surveillance sites should rapidly be established to monitor the
emergence of an epidemic of KS.
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